Biogen can't escape copay kickback lawsuits as Humana alleges 'seeding and sweeping' scheme
The Department of Justice made an example out of Biogen when it resolved allegations the drugmaker concocted a scheme to lure patients into taking its multiple sclerosis drugs by sponsoring their Medicare copays — which the feds say amount to illegal kickbacks. In a demonstration of accountability, Biogen paid $22 million to settle the claims.
One of Medicare’s contract insurers is now suing Biogen to get its own share of compensation.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 163,600+ biopharma pros reading Endpoints daily — and it's free.